KnowGovRepresentation. Influence. Action.
BillHR 9192 · 119

Prior Authorization Reform for Autoimmune and Blood Disorders Act

Introduced
Jun 8, 2026
Cosponsors
1
Traction
0
Last Action
Jun 8, 2026

Bill Summary

Requires health insurance companies to improve and speed up the prior authorization process for patients with autoimmune and blood disorders. Simplifies the process for patients to get necessary treatments and medications.

Sponsored By

Julie Johnson
Democrat · Texas · House

Bill Journey

  1. Jun 8, 2026
  3. Jun 8, 2026You Are Here

    The committee will review the bill, debate amendments, and vote on whether to advance it to the full chamber.

  4. TBD

    The full chamber debates the bill, may amend it, and votes on whether to pass it.

  5. TBD

    If passed by the first chamber, the other chamber considers, may amend, and votes on the bill.

  6. TBD

    If passed by both chambers, the bill goes to the President to sign into law or veto.

Why It Matters

Patients with autoimmune and blood disorders, such as rheumatoid arthritis and sickle cell disease, will have easier and faster access to necessary treatments and medications. Healthcare providers will also be affected, as they will have to implement the new prior authorization procedures.

Impact Areas

Sample
Addresses Supply
Targets an underlying shortage driving costs.
Supports Families
Aimed at easing pressure on working households.
Long-term Impact
Effects compound across multiple budget cycles.
Expands Access
Lowers barriers for first-time participants.

Support & Opposition

Sponsor & cosponsor support by party
1backer
  • Democratic1
Cross-party cosponsors0 · 0%

Documents

1

Full text opens on congress.gov, the official source.

Bill Details

Bill TypeHouse Bill · Federal
Primary Topic—
CommitteeCommittee on Energy and Commerce
IntroducedJun 8, 2026
Last UpdatedJun 8, 2026
Latest ActionReferred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Summary and impact analysis written by Judy (KnowGov's enrichment AI). Bill metadata, status, sponsor, and any floor votes from Prism. Sections marked “Sample” are placeholders not yet connected to live data.